These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34747805)

  • 1. Cortical and Subcortical Brain Area Atrophy in SCA1 and SCA2 Patients in India: The Structural MRI Underpinnings and Correlative Insight Among the Atrophy and Disease Attributes.
    Tamuli D; Kaur M; Sethi T; Singh A; Faruq M; Jaryal AK; Srivastava AK; Kumaran SS; Deepak KK
    Neurol India; 2021; 69(5):1318-1325. PubMed ID: 34747805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural atrophy of central autonomic network correlates with the functional attributes of autonomic nervous system in spinocerebellar ataxia patients.
    Tamuli D; Kaur M; Jaryal AK; Srivastava AK; Senthil Kumaran S; Deepak KK
    J Clin Neurosci; 2021 Nov; 93():274-281. PubMed ID: 34353716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
    Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
    Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics.
    Della Nave R; Ginestroni A; Tessa C; Salvatore E; De Grandis D; Plasmati R; Salvi F; De Michele G; Dotti MT; Piacentini S; Mascalchi M
    Neuroimage; 2008 Oct; 43(1):10-9. PubMed ID: 18672073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
    Guerrini L; Lolli F; Ginestroni A; Belli G; Della Nave R; Tessa C; Foresti S; Cosottini M; Piacentini S; Salvi F; Plasmati R; De Grandis D; Siciliano G; Filla A; Mascalchi M
    Brain; 2004 Aug; 127(Pt 8):1785-95. PubMed ID: 15240431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study.
    Goel G; Pal PK; Ravishankar S; Venkatasubramanian G; Jayakumar PN; Krishna N; Purushottam M; Saini J; Faruq M; Mukherji M; Jain S
    Parkinsonism Relat Disord; 2011 Aug; 17(7):521-7. PubMed ID: 21600833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.
    Della Nave R; Foresti S; Tessa C; Moretti M; Ginestroni A; Gavazzi C; Guerrini L; Salvi F; Piacentini S; Mascalchi M
    Neuroimage; 2004 Jun; 22(2):698-705. PubMed ID: 15193598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3.
    Klockgether T; Skalej M; Wedekind D; Luft AR; Welte D; Schulz JB; Abele M; Bürk K; Laccone F; Brice A; Dichgans J
    Brain; 1998 Sep; 121 ( Pt 9)():1687-93. PubMed ID: 9762957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracking longitudinal thalamic volume changes during early stages of SCA1 and SCA2.
    Grisoli M; Nigri A; Medina Carrion JP; Palermo S; Demichelis G; Giacosa C; Mongelli A; Fichera M; Nanetti L; Mariotti C
    Radiol Med; 2024 Aug; 129(8):1215-1223. PubMed ID: 38954239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
    Schulz JB; Borkert J; Wolf S; Schmitz-Hübsch T; Rakowicz M; Mariotti C; Schöls L; Timmann D; van de Warrenburg B; Dürr A; Pandolfo M; Kang JS; Mandly AG; Nägele T; Grisoli M; Boguslawska R; Bauer P; Klockgether T; Hauser TK
    Neuroimage; 2010 Jan; 49(1):158-68. PubMed ID: 19631275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
    Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
    Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in sleep stage R scoring in patients with autosomal dominant spinocerebellar ataxias (SCA1, SCA2 and SCA3) and oculomotor abnormalities: a whole night polysomnographic evaluation.
    Seshagiri DV; Sasidharan A; Kumar G; Pal PK; Jain S; Kutty BM; Yadav R
    Sleep Med; 2018 Feb; 42():97-102. PubMed ID: 29458753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
    Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
    Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy.
    Lirng JF; Wang PS; Chen HC; Soong BW; Guo WY; Wu HM; Chang CY
    PLoS One; 2012; 7(10):e47925. PubMed ID: 23118909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis and hierarchical clustering of infratentorial morphological MRI identifies SCAs phenogroups.
    Zhao J; Zeng W; Huang X; Hu M; Yuan K; Wu C; Qiu H; Chu J
    J Neurol; 2023 Sep; 270(9):4466-4477. PubMed ID: 37291395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressed baroreflex sensitivity from spontaneous oscillations of heart rate and blood pressure in SCA1 and SCA2.
    Tamuli D; Kaur M; Boligarla A; Jaryal AK; Srivastava AK; Deepak KK
    Acta Neurol Scand; 2019 Nov; 140(5):350-358. PubMed ID: 31343735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleus accumbens degeneration in spinocerebellar ataxia type 2: a preliminary study.
    Nakayama K; Nemoto K; Arai T
    Psychogeriatrics; 2024 Mar; 24(2):345-354. PubMed ID: 38243757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion tensor imaging of spinocerebellar ataxias types 1 and 2.
    Mandelli ML; De Simone T; Minati L; Bruzzone MG; Mariotti C; Fancellu R; Savoiardo M; Grisoli M
    AJNR Am J Neuroradiol; 2007; 28(10):1996-2000. PubMed ID: 17998418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural signature in SCA1: clinical correlates, determinants and natural history.
    Martins Junior CR; Martinez ARM; Vasconcelos IF; de Rezende TJR; Casseb RF; Pedroso JL; Barsottini OGP; Lopes-Cendes Í; França MC
    J Neurol; 2018 Dec; 265(12):2949-2959. PubMed ID: 30324307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.